Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cyclerion Therapeutics, Inc. (CYCN) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cyclerion Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1755237.
Total stock buying since 2019: $33,007,572.
Total stock sales since 2019: $240,021.
Total stock option exercises since 2019: $12,080.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 8 | $27 | 0 | $0 |
| 2021 | 2,880,862 | $8,427,794 | 4,461 | $17,817 | 0 | $0 |
| 2020 | 125,000 | $316,250 | 27,493 | $88,388 | 0 | $0 |
| 2019 | 1,647,341 | $24,263,528 | 53,922 | $133,789 | 2,000 | $12,080 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-08 | 0 | $0 | 8 | $27 | 0 | $0 |
| 2021-06 | 1,880,861 | $5,999,992 | 0 | $0 | 0 | $0 |
| 2021-05 | 1,000,001 | $2,427,802 | 0 | $0 | 0 | $0 |
| 2021-02 | 0 | $0 | 4,461 | $17,817 | 0 | $0 |
| 2020-12 | 0 | $0 | 20,107 | $60,522 | 0 | $0 |
| 2020-11 | 125,000 | $316,250 | 3,827 | $9,644 | 0 | $0 |
| 2020-02 | 0 | $0 | 3,559 | $18,222 | 0 | $0 |
| 2019-12 | 0 | $0 | 50,000 | $125,749 | 0 | $0 |
| 2019-11 | 125,000 | $227,500 | 3,922 | $8,040 | 0 | $0 |
| 2019-07 | 0 | $0 | 0 | $0 | 2,000 | $12,080 |
| 2019-04 | 1,522,341 | $24,036,028 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-09 | Mcguire Terrance (Director) | Sale | 8 | 3.40 | 27 |
| 2021-06-03 | Greenspan David Gerald | Buy | 961,538 | 3.12 | 2,999,998 |
| 2021-06-03 | Hecht Peter M (Chief Executive Officer) | Buy | 823,170 | 3.28 | 2,699,997 |
| 2021-06-03 | Mcguire Terrance (Director) | Buy | 96,153 | 3.12 | 299,997 |
| 2021-05-06 | Hecht Peter M (Chief Executive Officer) | Buy | 302,000 | 2.43 | 733,860 |
| 2021-05-05 | Hecht Peter M (Chief Executive Officer) | Buy | 398,001 | 2.53 | 1,006,942 |
| 2021-05-04 | Hecht Peter M (Chief Executive Officer) | Buy | 300,000 | 2.29 | 687,000 |
| 2021-02-25 | Gjino Anjeza (Chief Financial Officer) | Sale | 1,824 | 4.00 | 7,296 |
| 2021-02-25 | Wright Christopher I (Chief Medical Officer) | Sale | 2,637 | 3.99 | 10,521 |
| 2020-12-28 | Currie Mark G (President and CSO) | Sale | 20,107 | 3.01 | 60,522 |
| 2020-11-09 | Busch Andreas (Chief Innovation Officer) | Buy | 125,000 | 2.53 | 316,250 |
| 2020-11-06 | Huyett William (Chief Financial Officer) | Sale | 3,827 | 2.52 | 9,644 |
| 2020-02-21 | Huyett William (Chief Financial Officer) | Sale | 3,559 | 5.12 | 18,222 |
| 2019-12-30 | Currie Mark G (President) | Sale | 25,000 | 2.48 | 62,000 |
| 2019-12-27 | Currie Mark G (President) | Sale | 25,000 | 2.55 | 63,749 |
| 2019-11-15 | Busch Andreas (Chief Innovation Officer) | Buy | 125,000 | 1.82 | 227,500 |
| 2019-11-08 | Huyett William (Chief Financial Officer) | Sale | 3,922 | 2.05 | 8,040 |
| 2019-07-10 | Hecht Peter M (Chief Executive Officer) | Option Ex | 2,000 | 6.04 | 12,080 |
| 2019-04-08 | Schulman Amy W (Director) | Buy | 626,117 | 16.00 | 10,017,872 |
| 2019-04-08 | Mcguire Terrance (Director) | Buy | 626,117 | 16.00 | 10,017,872 |
| 2019-04-02 | Currie Mark G (President) | Buy | 270,107 | 14.81 | 4,000,284 |
Insider trading activities including stock purchases, stock sales, and option exercises of CYCN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cyclerion Therapeutics, Inc. (symbol CYCN, CIK number 1755237) see the Securities and Exchange Commission (SEC) website.